Stocks and Investing
Stocks and Investing
Wed, June 21, 2023
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Tue, June 20, 2023
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Bruce Jackson Reiterated (UNCY) at Buy and Held Target at $3 on, Jun 20th, 2023
Bruce Jackson of Benchmark, Reiterated "Unicycive Therapeutics, Inc." (UNCY) at Buy and Held Target at $3 on, Jun 20th, 2023.
Bruce has made no other calls on UNCY in the last 4 months.
There are 3 other peers that have a rating on UNCY. Out of the 3 peers that are also analyzing UNCY, 0 agree with Bruce's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Bruce
- Ed Arce of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $8 on, Wednesday, May 17th, 2023
- Elemer Piros of "EF Hutton" Reiterated at Strong Buy and Held Target at $5 on, Wednesday, May 17th, 2023
- Jason McCarthy of "Maxim Group" Maintained at Strong Buy with Increased Target to $6 on, Thursday, March 9th, 2023
Contributing Sources